about
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.Motoric Cognitive Risk Syndrome: Association with Incident Dementia and Disability.Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.New Therapeutic Strategies for Lewy Body Dementias.Early-onset mild cognitive impairment in Parkinson's disease: Altered corticopetal cholinergic network.The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson's Disease through NF-κB/pAKT Signaling Pathways.Prospective memory functioning in individuals with Parkinson's disease: a systematic review.Network connectivity determines cortical thinning in early Parkinson's disease progression.Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.Clinical Ethics in the Context of Deep Brain Stimulation for Movement Disorders.Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Parkinson disease: What goes around comes around: cognitive impairment as prodromal parkinsonism?Comprehensive grading of Parkinson's disease using motor and non-motor assessments: addressing a key unmet need.Serotonin, beta-amyloid, and cognition in Parkinson disease.Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes.Resting State fMRI: A Valuable Tool for Studying Cognitive Dysfunction in PD.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years.A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical studyNucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's diseaseMicroglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
P2860
Q38669168-A0BFB680-6984-4470-B59A-9C405A63D4A7Q38742991-1BAD29D4-6D0E-49D6-ACEE-5491EDEB7753Q39332667-985BB09E-9836-4CA7-A96A-7B5B3B996102Q39456457-36C5E0E7-60BA-4F67-9494-8C41806B2075Q42218622-5EF0FFB5-3064-444A-979D-4E1CDB3AF310Q42364022-A0BDC1A7-AA78-4C03-AA02-480D2F1DCA67Q43375910-5C02765E-855E-475C-9EB6-CFB03126ADEAQ47222156-6A65B72D-37F6-4D28-9AED-D982241AEAFBQ47402058-FB2C1DEA-452B-485F-ADAE-DB32615B7D05Q47566459-56EE150F-55A8-4B0F-B132-43A93AC94A93Q47720903-EA3CEC07-7D76-4C27-BFCE-8CB97791BDFAQ47849289-6F30C243-021E-4969-9828-2DF1C9AD421FQ48020472-7ED1FADE-C311-4D5A-96F1-CBB16A5AF142Q48091456-EE1A2D11-8019-4B0D-8F0C-E6576D5FE5C2Q48181201-E3556E48-934F-42C7-9714-01CEFA25DBA4Q49987358-FD3AC814-8CD5-4E4E-B06F-4DF2E0422F73Q50082384-EA0B3640-DE6B-45D6-B3AE-1955855C7136Q50222039-5B678FBE-9189-44AA-9939-C2A468DEA94AQ52582953-3813B3BF-F768-47D4-AF33-7559AB10518AQ52663753-0E8E0F6D-7B33-47BA-BB31-41C3959DB155Q54920002-C8D19B90-11A7-4D2A-B93C-ED3F61A3F597Q54982491-9A6D7D2E-F923-4DAE-8766-91E0AF8B2C72Q55279689-D41376AB-1980-480A-8CCD-6561295986F4Q55460606-ED954ED8-A92D-430C-99DD-BE617A1607BCQ55618860-978ABD5C-17AA-4C6F-A801-C9AE0A0F538AQ55690891-FF3991E2-B1A2-4375-948A-F94EA4C44986Q57493673-F0EB42E8-E6F8-4D94-A5DD-EF29FBA5CD45Q57663489-3664B8AF-44C0-4D3D-92BF-A35E0AB60D50Q58799080-07B7C4E4-9F32-421A-AD49-A74E6D28C7BB
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cognitive decline in Parkinson disease.
@en
type
label
Cognitive decline in Parkinson disease.
@en
prefLabel
Cognitive decline in Parkinson disease.
@en
P2860
P50
P356
P1476
Cognitive decline in Parkinson disease.
@en
P2093
Byron Creese
Marios Politis
P2860
P2888
P304
P356
10.1038/NRNEUROL.2017.27
P407
P577
2017-03-03T00:00:00Z
P6179
1084129807